Hired and retired: New year, new job

By Rachel Arthur

04-Jan-2022 - Last updated on 04-Jan-2022 at 12:44 GMT

We take a look at some of the people starting 2022 with a new role in the biopharma industry.

Hired and retired

GSK: Phil Dormitzer M.D., Ph.D

Cartesian Therapeutics: Senior Advisors

Obsidian Therapeutics: Lee Giguere

Corbus Pharmaceuticals: Rachael Brake, Ph.D.

Gamma Biosciences: Dave Gordon

Related news

Show more

Gates MRI looks to Phase 3 tuberculosis vaccine trial with epidemiology study
Moderna’s Australian mRNA manufacturing facility set to become operational in 2024
Nutcracker Therapeutics raises $167m to advance mRNA biochip-based manufacturing platform
WHO establishes global biomanufacturing training hub in Korea

Follow us

Webinars

On-demand webinars

Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROS Mixed-Mode Chromatography Media Thermo Fisher Scientific - Biosciences

Headlines

Follow us